Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in antiepileptic drug therapy

M C Walker1, J W Sander

  • 1University Department of Clinical Neurology, Institute of Neurology, London, UK.

Current Opinion in Neurology
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy.

Seizure·2026
Same author

African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health.

Neuroscience·2025
Same author

High prevalence of epilepsy in Southern and Northern Rwanda: Myth or reality?

Tropical medicine & international health : TM & IH·2024
Same author

Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy".

Journal of the neurological sciences·2021
Same author

The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers.

Epilepsy & behavior reports·2021
Same author

CARTR Plus: the creation of an ART registry in Canada.

Human reproduction open·2020
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

New antiepileptic drugs are progressing, with novel designs and improved formulations. Further comparative studies are needed to guide optimal drug treatment for epilepsy.

Area of Science:

  • Pharmacology
  • Neurology
  • Drug Development

Background:

  • Epilepsy treatment is evolving with new antiepileptic drugs (AEDs) and formulations.
  • Advances in understanding epilepsy's molecular basis may lead to rationally designed AEDs.
  • Current clinical practice benefits from both established and emerging AEDs.

Purpose of the Study:

  • To review recent progress in promising antiepileptic drugs.
  • To discuss novel AEDs and improved formulations of existing drugs.
  • To highlight the need for comparative studies in epilepsy pharmacotherapy.

Main Methods:

  • Review of recently developed and clinically used antiepileptic drugs.
  • Examination of new drug formulations and pharmacokinetic improvements.

Related Experiment Videos

  • Analysis of specific drugs including felbamate, lamotrigine, vigabatrin, zonisamide, gabapentin, stiripentol, carbamazepine, and oxcarbazepine.

    • Main Results:

    • Several antiepileptic drugs like felbamate, lamotrigine, vigabatrin, zonisamide, and gabapentin are in clinical use.
    • Newer agents and improved formulations, such as controlled-release carbamazepine and oxcarbazepine, are available.
    • Stiripentol and other potential AEDs are also under review for their efficacy.

    Conclusions:

    • Significant progress is being made in the development of novel antiepileptic drugs and improved drug formulations.
    • While promising AEDs are emerging, robust comparative studies are essential for evidence-based treatment guidelines.
    • The future of epilepsy management lies in a combination of rational drug design and rigorous clinical evaluation.